Home
  >  
Section 13
  >  
Chapter 12,612

Synthesis and molecular modelling of novel substituted-4,5-dihydro- (1H) -pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors

Chimenti, F.; Bolasco, A.; Manna, F.; Secci, D.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Alcaro, S.; Ortuso, F.

Chemical Biology and Drug Design 67(3): 206-214

2006

ISSN/ISBN: 1747-0277
PMID: 16611214
DOI: 10.1111/j.1747-0285.2006.00367.x
Accession: 012611231
Download citation:  
Text
  |  
BibTeX
  |  
RIS
This report describes novel pyrazoline derivatives investigated for their ability to selectively inhibit the activity of the A and B isoforms of monoamine oxidase. These new synthetic compounds proved to be reversible, potent, and selective inhibitors of monoamine oxidase-A rather than of monoamine oxidase-B, and are promising candidates to further advance drug discovery efforts. The most active compounds show inhibitory activity on monoamine oxidase-A in the 1.0x10(-8)-8.6x10(-9) M range. Moreover, it should be pointed out that for some compounds a high IC50>or=10(-9) M value is associated with a high A-selectivity (Selectivity Index monoamine oxidase-B/monoamine oxidase-A in the 10,000-12,500 range). Further insight to understand enzyme-inhibitor molecular interaction was obtained by docking experiments with the monoamine oxidase-A and monoamine oxidase-B isoforms.

PDF emailed within 0-6 h: $19.90




Related References

Chimenti, F.; Bolasco, A.; Manna, F.; Secci, D.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Cirilli, R.; La Torre, F.; Alcaro, S.; Ortuso, F.; Langer, T. 2006: Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase a inhibitors Current Medicinal Chemistry 13(12): 1411-1428
Chimenti, F.; Maccioni, E.; Secci, D.; Bolasco, A.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Alcaro, S.; Ortuso, F.; Cirilli, R.; La Torre, F.; Cardia, M.C.; Distinto, S. 2005: Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives Journal of Medicinal Chemistry 48(23): 7113-7122
Cheng, H.; Lundy DeMello, K.M.; Li, J.; Sakya, S.M.; Ando, K.; Kawamura, K.; Kato, T.; Rafka, R.J.; Jaynes, B.H.; Ziegler, C.B.; Stevens, R.; Lund, L.A.; Mann, D.W.; Kilroy, C.; Haven, M.L.; Nimz, E.L.; Dutra, J.K.; Li, C.; Minich, M.L.; Kolosko, N.L.; Petras, C.; Silvia, A.M.; Seibel, S.B. 2006: Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors Bioorganic and Medicinal Chemistry Letters 16(8): 2076-2080
Xiao, X.; Zhang, X.-X.; Zhan, M.-M.; Cheng, K.; Li, S.; Xie, Z.; Liao, C. 2018: Design, synthesis and bioevalucation of novel 2,3-dihydro-1H-inden-1-amine derivatives as potent and selective human monoamine oxidase B inhibitors based on rasagiline European Journal of Medicinal Chemistry 145: 588-593
Meddad-Belhabich, N.; Aoun, D.; Djimdé, A.é; Redeuilh, C.; Dive, G.; Massicot, F.; Chau, F.ço.; Heymans, F.ço.; Lamouri, A. 2010: Design of new potent and selective secretory phospholipase A(2) inhibitors. 6-Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives Bioorganic and Medicinal Chemistry 18(10): 3588-3600
Koç, G.Ş; Tan, O.U.; Uçar, G.; Yildirim, E.; Erol, K.; Palaska, E. 2014: Synthesis and monoamine oxidase inhibitory activities of some 3-(4-fluorophenyl)-5-aryl-n-substituted-4,5-dihydro-(1H)-pyrazole-1-carbothioamide derivatives Drug Research 64(11): 591-598
Chimenti, F.; Bolasco, A.; Manna, F.; Secci, D.; Chimenti, P.; Befani, O.; Turini, P.; Giovannini, V.; Mondovì, B.; Cirilli, R.; La Torre, F. 2004: Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase Journal of Medicinal Chemistry 47(8): 2071-2074
Sentürk, K.; Tan, O.Unsal.; Ciftçi, S.Yabanoğlu.; Uçar, Gülberk.; Palaska, E. 2012: Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives Archiv der Pharmazie 345(9): 695-702
Özdemir, Z.; Alagöz, M.A.; Uslu, H.; Karakurt, A.; Erikci, A.; Ucar, G.; Uysal, M. 2020: Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors Pharmacological Reports: Pr 72(3): 692-704
Lebreton, L.; Curet, O.; Gueddari, S.; Mazouz, F.; Bernard, S.; Burstein, C.; Milcent, R. 1995: Selective and potent monoamine oxidase type B inhibitors: 2-substituted 5-aryltetrazole derivatives Journal of Medicinal Chemistry 38(24): 4786-4792
Sterling, J.; Veinberg, A.; Lerner, D.; Goldenberg, W.; Levy, R.; Youdim, M.; Finberg, J. 1998: N-Propargyl-1-aminoindan and derivatives Highly selective and potent inhibitors of monoamine oxidase B Journal of Neural Transmission Suppl 52: 301-305
Sterling, J.; Veinberg, A.; Lerner, D.; Goldenberg, W.; Levy, R.; Youdim, M.; Finberg, J. 1998: (R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B Journal of Neural Transmission. Supplementum 52: 301-305
Pisani, L.; Muncipinto, G.; Miscioscia, T.Fabiola.; Nicolotti, O.; Leonetti, F.; Catto, M.; Caccia, C.; Salvati, P.; Soto-Otero, R.; Mendez-Alvarez, E.; Passeleu, C.; Carotti, A. 2009: Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor Journal of Medicinal Chemistry 52(21): 6685-6706
Kong, H.; Meng, X.; Hou, R.; Yang, X.; Han, J.; Xie, Z.; Duan, Y.; Liao, C. 2021: Novel 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol derivatives as potent selective human monoamine oxidase B inhibitors: Design, SAR development, and biological evaluation Bioorganic and Medicinal Chemistry Letters 43: 128051
Abdelhafez, O.M.; Amin, K.M.; Ali, H.I.; Abdalla, M.M.; Batran, R.Z. 2012: Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase a inhibitors Journal of Medicinal Chemistry 55(23): 10424-10436
Lan, J.; Pan, L.; Xie, S.; Wang, X.; Kong, L. 2015: Synthesis and evaluation of 6-methylcoumarin derivatives as potent and selective monoamine oxidase B inhibitors MedChemComm 6(4): 592-600
Pisani, L.; Catto, M.; Nicolotti, O.; Grossi, G.; Di Braccio, M.; Soto-Otero, R.; Mendez-Alvarez, E.; Stefanachi, A.; Gadaleta, D.; Carotti, A. 2013: Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors European Journal of Medicinal Chemistry 70: 723-739
Gökhan-Kelekçi, N.; Simşek, O.O.ün.; Ercan, A.şe.; Yelekçi, K.; Sahin, Z.S.; Işik, S.; Uçar, G.ül.; Bilgin, A.A. 2009: Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors Bioorganic and Medicinal Chemistry 17(18): 6761-6772
Mathew, B.; Oh, J.M.; Abdelgawad, M.A.; Khames, A.; Ghoneim, M.M.; Kumar, S.; Nath, L.R.; Sudevan, S.T.; Parambi, D.G.T.; Agoni, C.; Soliman, M.E.S.; Kim, H. 2022: Conjugated Dienones from Differently Substituted Cinnamaldehyde as Highly Potent Monoamine Oxidase-B Inhibitors: Synthesis, Biochemistry, and Computational Chemistry Acs Omega 7(9): 8184-8197
Palaska, E.; Aydin, F.; Uçar, G.ül.; Erol, D. 2008: Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives Archiv der Pharmazie 341(4): 209-215